A scientific article reporting unintended effects of the CRISPR gene-editing technique has riled executives of companies hoping to commercialize the technology. But they’re arguing on the wrong side of the science, reports Claire Robinson
Source
A scientific article reporting unintended effects of the CRISPR gene-editing technique has riled executives of companies hoping to commercialize the technology. But they’re arguing on the wrong side of the science, reports Claire Robinson